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ABSTRACT: Scenario-based analyses were
computed for benefits and costs linked with
hypothetical oral rabies vaccination (ORV)
campaigns to contain or eliminate skunk-variant
rabies in skunks (Mephitis mephitis) in Cali-
fornia, USA. Scenario 1 assumed baiting eight
zones (43,388 km2 total) that comprised 73% of
known skunk rabies locations in the state.
Scenario 2 also assumed baiting these eight
zones, but further assumed that added benefits
would result from preventing the spread of
skunk-variant rabies into Los Angeles County,
USA. Scenarios assumed a fixed bait cost ($1.24
each) but varied campaigns (one, two and three
annual ORV applications), densities of baits
(37.5/km2, 75/km2 and 150/km2), levels of
prevention (50%, 75%, and 100%), and con-
tingency expenditures if rabies recurred (20%,
40%, and 60% of campaign costs). Prorating
potential annual benefits during a 12-yr time
horizon yielded benefit-cost ratios (BCRs)
between 0.16 and 2.91 and between 0.34 and
6.35 for Scenarios 1 and 2, respectively.
Economic issues relevant to potentially manag-
ing skunk-variant rabies with ORV are dis-
cussed.
Key words: Benefit-cost analysis, Califor-
nia, economics, oral vaccination, rabies,
skunks.
Oral rabies vaccination (ORV) of wild-
life was first used in the 1970s to manage
red fox (Vulpes vulpes) rabies in Europe
(Steck et al., 1982; Winkler and B}ogel,
1992). In ORV campaigns, bait-containing
packets of specific vaccines are distributed
onto the landscape at prescribed densities,
which allows targeted animals to forage on
the bait matrix and self-dose with the
vaccine (Johnston and Tinline, 2002).
In 2003, the California Department of
Health Services (CDHS) began to re-
search the impacts of skunk (Mephitis
mephitis) rabies and to assess the feasibil-
ity of using ORV to reduce these impacts
(Sterner et al., in press). Although no
rabies vaccine or bait for skunks is
currently available, development and pro-
duction may be imminent (Dietzschold et
al., 2003; Rupprecht et al., 2006). Stripped
skunks and bats (Chiroptera) are the main
reservoirs of wildlife rabies in the state
(Krebs et al., 2005).
We computed scenario-based, benefit-
cost analyses to assess the hypothetical use
of ORV technology to control skunk-
variant rabies in California. Analyses
sought to reduce the economic uncertain-
ty associated with a future ORV program.
These economic outcomes would be
integrated with other information (e.g.,
budgetary constraints, sociopolitical con-
cerns) to facilitate future decisions on
ORV in skunks by natural resource
managers, public health officials, and
policy makers. All analyses incorporated
historic case and empirical cost data.
Specific latitude-longitude locations
were obtained for 1,785 of 2,032 (87.8%)
rabid skunks submitted for rabies diag-
nostic tests in California between 1992
and 2003 inclusive (Sterner et al., 2008).
Areas of dense skunk-rabies cases were
identified using the Spatial Analyst Pro-
gram of ArcViewH 3.2 Geographic Infor-
mation System (GIS) software (ESRI,
Redlands, California, USA). Potential
ORV bait zones were derived using a
density algorithm, which spreads the point
values over a raster surface (grid). Select-
ed ORV zones had densities of between
0.030 and 0.245 skunk rabies cases/km2. A
16-km-wide buffer was then imposed
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around identified clusters of cases (i.e.,
,0.030 cases/km2 of skunk-rabies cases
surrounding designated ORV zones and
excluding over-water areas). Eight hot
spots plus buffers, encompassing
43,388 km2 and containing 1,489 of the
rabid skunk locations (i.e., 73.3% of the
known rabid-skunk locations), were delin-
eated using this method (Fig. 1).
Two scenarios were devised to estimate
potential ORV-induced benefits. Scenario
1 assumed baiting the eight hotspots plus
buffers to directly control skunk-variant
rabies (Fig. 1); benefits included savings
accrued from projected reductions in
human postexposure prophylaxis (PEP)
treatments and skunk-rabies diagnostic
tests (see Shwiff et al., 2007). Scenario 2
assumed baiting these same eight zones,
recouping the Scenario 1 benefits, plus
garnering added savings from the prevent-
ed spread of skunk rabies into densely
populated Los Angeles County, USA. Los
Angeles County, USA, was not within the
hot-spot zones, but it was assumed in
Scenario 2 that baiting prevented skunk
rabies from spreading to this heavily
populated area. To estimate the additional
benefit of prevented spread, we derived a
population-based rate of human exposure
and skunk-diagnostic testing similar to
those reported for Santa Barbara and
San Luis Obispo counties, USA (Shwiff
et al., 2007); then we extrapolated these
potential empirical rates using the human
population (United States Bureau of
Census, 2000) in Los Angeles County,
USA.
Benefit-cost methodology was used in
the analyses (Meltzer, 1996; Zerbe and
Dively, 1994). Benefit-cost ratios (BCRs)
were calculated using the ratio of benefits
and costs. The BCRs for skunk ORV were
derived for Scenarios 1 and 2 through the
monetary value of skunk specimen collec-
tions, tests, and human exposure costs
saved during a future 12-yr time horizon





~ $ Value of skunkð
collection and test and human exposure
costs saved 7$ Cost of ORV baitingÞð1Þ
A BCR of 1.0 indicated that the benefits
and costs were equal—one unit of costs
yielded one unit of benefits.
Five parameters determined ORV costs:
1) area of bait application (in square
kilometers), 2) bait price (dollars/bait), 3)
bait density (baits/square kilometer), 4)
campaigns (n), and 5) mode of bait
distribution (i.e., fixed-winged aircraft
and ground baiting), with possible contin-
gency costs included for rebaiting (per-
centage of original campaign costs). These
assumptions were based upon the current
program for ORV baiting of raccoons
(Procyon lotorin) in the eastern United
States. Computations were derived using
the 43,388 km2 comprising the eight ORV
zones (Fig. 1), a price of $1.24/bait (Slate
FIGURE 1. Map of California, USA, Geographic
Information System (GIS)–located skunk-rabies cas-
es from 1992 to 2003, showing eight, dense hot spots
with 16-km buffers hypothesized as potential oral
rabies vaccination (ORV) bait zones.
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et al. 2005), three bait densities (37.5, 75,
and 150 baits/km2), and three campaign
frequencies (1, 2, or 3 campaigns annual-
ly). Empirical cost estimates for fixed-
winged transects and ground-baiting,
based upon topographic analysis, surveil-
lance, project planning (including person-
nel costs), and ORV evaluation costs for
the eight zones, were obtained using the
Vaccine Application Control Center (Na-
tional Rabies Management Program,
2005). This software contained calcula-
tions used to determine the cost of the
ORV baiting of raccoons in the eastern
United States. Contingency costs (i.e., to
control unexpected recurrence of rabid
skunks in the zones) were arbitrarily set at
20%, 40%, and 60% of original ORV
campaign costs, with BCRs recalculated
for both Scenarios 1 and 2 to reflect
assumed 50% and 75% prevention of
future human exposure and skunk diag-
nostic testing with the contingency spend-
ing.
Historic rabies case data allowed for the
determination of potential benefits for
Scenarios 1 and 2. Shwiff et al. (2007)
reported a study of direct (e.g., PEP,
patient copayment) and indirect (e.g.,
public health investigation, animal control
activities, patient incidentals for travel,
child care, alternative medicines) costs of
human exposure and animal testing in
Santa Barbara and San Luis Obispo
counties, USA (1998 to 2002 data). Results
showed that each human exposure had a
mean cost of $3,688 (in 2004 US dollars).
Shwiff et al. (2007) also reported a mean
cost of $424 (in 2004 US dollars) for the
collection, shipment, preparation, and
rabies diagnostic testing of each animal
specimen. An arbitrary 10-yr average of
skunk examinations and tests between
1991 and 2000 for the state was 1,128,
with 214 (19.0%) of these specimens
positive for rabies, and of those 214, an
average of 19 (8.9%) resulting in human
PEP treatments (Sterner et al., 2008). We
extrapolated from these data the human
population-based projections of case loads
as benefits of ORV baiting to the areas
described for Scenarios 1 and 2.
A single application of baits over the
eight ORV zones was estimated to cost
$2,260,668 (37.5 baits/km2), $3,831,964
(75 baits/km2), and $7,016,779 (150 baits/
km2) in 2004 US dollars, respectively
(Table 1). For these three estimates, the
cost of bait made up approximately 67%,
81%, and 89% of the total, respectively. As
bait densities were doubled, total costs
increased nonlinearly—fuel and flight
time costs stayed constant, whereas bait
costs doubled. Zone 2, centered on Butte
and Sutter counties, USA, was the largest
ORV zone (19,612 km2) and contained
876 skunk rabies cases; this zone account-
ed for <50% of the total ORV expenses
(Table 1). Zone 8, centered on Santa
Barbara and San Luis Obispo counties,
USA, was the second largest ORV zone
(9,853 km2), with 345 rabid skunks re-
ported; this zone accounted for <20% of
the total ORV costs.
Results showed that the potential,
average, annual, eight-zone expense for
scenario 1 was $548,344, with 50%, 75%,
and 100% deterrence of cases expected to
yield annual potential benefits of
$274,172, $411,258, and $548,344, respec-
tively (Table 2). These represented the
maximum annual benefits that could be
recouped from ORV. Human PEP treat-
ments accounted for <13% ($70,072) of
TABLE 1. Baiting costs for 8 oral rabies vaccination





1 158,582 268,040 490,015
2 1,041,670 1,777,444 3,269,561
3 125,222 211,425 386,241
4 96,977 160,790 290,201
5 194,915 310,859 544,283
6 72,143 124,712 231,320
7 89,671 152,225 279,081
8 481,488 826,470 1,526,076
Total 2,260,668 3,831,964 7,016,779
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these benefits. Additionally, inclusion of
projected human exposure and skunk
diagnostic testing for Los Angeles County,
USA, more than doubled potential rabies-
incurred costs (Scenario 2 benefits).
For Scenario 1, BCRs for all combina-
tions of campaign, bait density, and skunk
rabies prevention variables ranged between
0.16 and 2.91 (Table 3). No combinations
of the bait density and skunk rabies
prevention variables involving three cam-
paigns yielded BCRs$1.0 (Table 3). Seven
conditions emerged as economically effi-
cient (BCRs$1.0) for one to two baitings.
Computed BCRs decreased as bait densi-
ties and campaigns increased, but BCRs
were greater as the assumed prevention of
future skunk cases improved from 50% to
75% to 100%. As expected, inclusion of
contingency baiting costs degraded BCRs
in Scenario 1 (Table 4). Only six combina-
tions of the ORV variables with contingen-
cy costs yielded BCRs$1.0, and all of these
occurred for one ORV campaign at 37.5
baits/km2 or 75 baits/km2.
For Scenario 2, results yielded greater
potential benefits and economic efficien-
cy. All combinations of the 37.5 baits/km2,
one to three campaigns, and 50% to 100%
prevention of future human exposure and
skunk diagnostic testing yielded
BCRs$1.0 (Table 3). Efficiency was also
achieved at the 75 baits/km2 for one to two
campaigns, assuming 100% prevention of
skunk rabies, as well as for one to two
campaigns at 75% prevention, and one
campaign at 50% prevention. The esti-
mated annual potential benefit was
$1,199,328 (Table 2). These benefits were
attributed to $548,344 from the eight
zones in Scenario 1 and the additional
$650,984 from the projected savings that
an ORV program would afford in prevent-
ed human exposure and skunk diagnostic
testing to Los Angeles County, USA. That
is, we projected that Los Angeles County,
USA, would expend $532,968 (1,2573
TABLE 2. Annual potential benefits associated with
Scenarios 1 and 2.
Scenario/site




Scenario 1 478,272 70,072 548,344
Scenario 2 1,011,240 188,088 1,199,328
Los Angeles County,
USA, only 532,968 118,016 650,984
TABLE 3. Benefit-cost ratios (BCRs) of rabies campaigns for Scenarios 1 and 2 at different prevention rates,





37.5 75 150 37.5 75 150 37.5 75 150
Scenario 1
1 2.91* 1.72* 0.94 2.18* 1.29* 0.70 1.46* 0.86 0.47
2 1.46* 0.86 0.47 1.09* 0.64 0.35 0.73 0.43 0.23
3 0.97 0.57 0.31 0.73 0.43 0.23 0.49 0.29 0.16
Scenario 2
1 6.35* 3.75* 2.05* 4.76* 2.81* 1.54* 3.18* 1.87* 1.02*
2 3.18* 1.87* 1.02* 2.38* 1.41* 0.77 1.59* 0.94 0.51
3 2.12* 1.25* 0.68 1.59* 0.94 0.51 1.06* 0.62 0.34
a The economically efficient BCRs are marked with an asterisk (*).
b Scenarios assumed a fixed bait cost ($1.24 each) but varied campaigns (one, two and three annual ORV applications),
densities of baits (37.5/km2, 75/km2, and 150/km2), levels of prevention (50%, 75%, and 100%), and contingency
expenditures if rabies recurred (20%, 40%, and 60% of campaign costs).
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$424) and $118,016 (323$3,688) for
annual skunk diagnostic and PEP costs,
respectively, by extrapolating historic inci-
dent frequencies (Shwiff et al., 2007).
Inclusion of these potential benefits af-
forded more options for economic effi-
ciency with Scenario 2 (Table 3). Further-
more, in contrast to Scenario 1, a total of
23 combinations of the ORV variables for
Scenario 2 with contingency costs yielded
BCRs$1.0, with most of these contingen-
cy situations (n514; 61%) involving one
campaign (Table 4).
Results imply that the economic feasi-
bility of an ORV program to control
skunk-variant rabies in California, USA,
will be likely for short-duration control
efforts (i.e., less than three annual ORV
campaigns will be efficient) involving low-
bait densities (i.e., 37.5 baits/km2 or 75
baits/km2), low contingency costs (i.e.,
20% or 40% of original costs), and
prolonged (i.e., 12 yr) suppression. To
date, published studies have shown that
rabies ORV programs are usually lengthy.
Reported programs in Canada and the
United States have generally exceeded
7 yr (e.g., MacInnes et al., 2001; Sidwa
et al., 2005; Slate et al., 2005). These
studies have also described prolonged,
postprogram, enhanced surveillance (i.e.,
increased public health monitoring, rabies
analyses of road-killed target animals, and
rabies analyses of trapped samplings of
target animals) and establishment of
maintenance ORV zones to prevent po-
tential reinfection of resident animals
from original foci or adjacent untreated
areas (MacInnes et al., 2001; Sidwa et al.,
2005; Slate et al., 2005).
For the raccoon, coyote (Canis latrans),
and gray fox (Urocyon cinereoargenteus)
ORV efforts in the United States, baits and
bait applications have proved to be
relatively expensive (Sidwa et al., 2005;
Slate et al., 2005). These baits were
produced at a cost of about $1.00 to
$1.27 (in 2005 US dollars, depending on
bait type) for federal use (Slate et al.,
2005). Baiting densities differ greatly
between red and gray fox and coyote
(<20–25/km2) and raccoon (<65–75/km2)
programs (Fearneyhough, et al., 1998;
MacInnes et al., 2001; Sidwa et al., 2005;
Slate et al., 2005). Although it is estimated
by the authors that effective bait densities
TABLE 4. Benefit-cost ratios (BCRs) of rabies campaigns for Scenarios 1 and 2 with contingency
expenditures for rabies recurrence at different prevention rates, bate densities, and numbers of batings.a








Prevent 75% Prevent 50%
Bait density (No./km2) Bait density (No./km2)
37.5 75 150 37.5 75 150 37.5 75 150 37.5 75 150
1 Baiting 1 Baiting
20 1.82 1.07 0.59 1.21 0.72 0.39 20 3.97 2.34 1.28 2.65 1.56 0.85
40 1.56 0.92 0.50 1.04 0.61 0.33 40 3.40 2.01 1.10 2.27 1.34 0.73
60 1.36 0.80 0.44 0.91 0.54 0.29 60 2.98 1.76 0.96 1.99 1.17 0.64
2 Baitings 2 Baitings
20 0.91 0.54 0.29 0.61 0.36 0.20 20 1.99 1.17 0.64 1.32 0.78 0.43
40 0.78 0.46 0.25 0.52 0.31 0.17 40 1.70 1.00 0.55 1.13 0.67 0.37
60 0.68 0.40 0.22 0.45 0.27 0.15 60 1.49 0.88 0.48 0.99 0.59 0.32
3 Baitings 3 Baitings
20 0.61 0.36 0.20 0.40 0.24 0.13 20 1.32 0.78 0.43 0.88 0.52 0.28
40 0.52 0.31 0.17 0.35 0.20 0.11 40 1.13 0.67 0.37 0.76 0.45 0.24
60 0.45 0.27 0.15 0.30 0.18 0.10 60 0.99 0.59 0.32 0.66 0.39 0.21
a Scenarios assumed a fixed bait cost ($1.24 each) but varied campaigns (one, two and three annual ORV applications),
densities of baits (37.5/km2, 75/km2, and 150/km2), levels of prevention (50%, 75%, and 100%), and contingency
expenditures if rabies recurred (20%, 40%, and 60% of campaign costs).
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for skunks will be low, the density will
require field testing and validation.
Inclusion of unexpected contingency
costs in economic assessments of ORV
related to incomplete elimination or con-
trol of rabies is prudent. Russell et al.
(2005) described a 2004 breach of the
Ohio-Pennsylvania, USA, ORV barrier for
raccoon-variant rabies that led to costly
trap-vaccinate-release, added ORV, and
tests of more than 300 raccoon specimens
to secure the former interstate barrier.
Granted, the size of the area that would
need to be rebaited is subject to specula-
tion (Russell et al., 2005), but even low
contingency costs (20% of campaign costs)
would compromise the use of ORV in
some of our scenarios.
In conclusion, our analyses have limited
a wide array of options that could be used
to evaluate future skunk-variant ORV
campaigns in California, USA. Whether a
county, group of counties, or a statewide
program would be undertaken is un-
known. Nevertheless, our analyses provide
information that can be used to reduce the
uncertainties of initiating such campaigns.
We thank K. Kirkpatrick for editorial
assistance and preparation of tables; J.
Bourassa prepared Figure 1. We also
thank R. McLean and K. Fagerstone for
initial critiques of the manuscript. Use of
trade names does not constitute endorse-
ment by the Federal Government.
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